Difference between revisions of "Team:UST Beijing/Model"

Line 145: Line 145:
 
<div class="col-md-8 col-md-offset-2">
 
<div class="col-md-8 col-md-offset-2">
 
<h1 class="intro-lead">Model</h1>
 
<h1 class="intro-lead">Model</h1>
<p>β-galactosidase is used to deglycosylate saponin of notoginseng. Our Lab have a PET-28a plasmid withβ-galactosidase gene and LacI gene. The transcription of β-galactosidase is repressed by LacI protein. But lactose and IPTG can induce the expression of LacI protein. We used a 3L fermentation tank to conduct preliminary experiments, then the enzyme was extracted from bacteria solution using glycine buffer.</p>
+
<p></p>
 
</div>
 
</div>
 
</div>
 
</div>
Line 170: Line 170:
  
 
<div id="part1"><h2>Enzyme activity</h2>
 
<div id="part1"><h2>Enzyme activity</h2>
 
+
<img src="https://static.igem.org/mediawiki/2016/5/52/T--UST_Beijing--recobination02.png" style="width:700px;"></br>
 
<img src="https://static.igem.org/mediawiki/2016/5/57/T--UST_Beijing--model01.png" style="width:700px;"></br>
 
<img src="https://static.igem.org/mediawiki/2016/5/57/T--UST_Beijing--model01.png" style="width:700px;"></br>
 
<img src="https://static.igem.org/mediawiki/2016/3/39/T--UST_Beijing--model02.png" style="width:700px;"></br>
 
<img src="https://static.igem.org/mediawiki/2016/3/39/T--UST_Beijing--model02.png" style="width:700px;"></br>
  
<p class="animate-box">As Chinese traditional medicinal materials, notoginseng has been widely recognized on its efficacy by Chinese people during thousands of years. With the developing of modern medicine, other characteristics of notoginseng have been utilizing. Now it’s been proved that notoginsenoside has therapeutic effect on hyperlipidemia and cardiovascular diseases. However, the bioavailability of saponin of notoginseng in human body can reach only 4%. Based on this premise, we hope to hydrolyze glycosyl on saponin of notoginseng molecule out of body, so that deglycosylated saponin of notoginseng can be easy for human to absorb.</p>
+
<p class="animate-box">β-galactosidase is used to deglycosylate saponin of notoginseng. Our Lab have a PET-28a plasmid withβ-galactosidase gene and LacI gene. The transcription of β-galactosidase is repressed by LacI protein. But lactose and IPTG can induce the expression of LacI protein. We used a 3L fermentation tank to conduct preliminary experiments, then the enzyme was extracted from bacteria solution using glycine buffer. The result showed us that extracted solution has strong ability to hydrolyze glycosyl. However, there’s no lactose in notoginseng solid medium. In order to reduce costs, another plasmid psb1C3 which contains T7 RNA Polymerase gene and was transformed into E.coli. Psb1C3 contains T7 RNA Polymerase gene and can be regulated by pBAD. This double-plasmid system is expected to be regulated by pPAD, and expresses a large number of T7RNA polymerase to inhibit the effect of LacI repression, switch on the expression ofβ-galactosidase. It’s been reported in bibliography that the cellwall of notoginseng contains a certain concentration of arabinose. Our ultimate goal is using notoginseng to provide nutrients for E.coli in a solid state fermentation jar, E.coli can deglycosylate saponin of notoginseng as well.</p>
  
  

Revision as of 04:00, 15 October 2016

iGEM team wiki of UST_Beijing

Model

Enzyme activity




β-galactosidase is used to deglycosylate saponin of notoginseng. Our Lab have a PET-28a plasmid withβ-galactosidase gene and LacI gene. The transcription of β-galactosidase is repressed by LacI protein. But lactose and IPTG can induce the expression of LacI protein. We used a 3L fermentation tank to conduct preliminary experiments, then the enzyme was extracted from bacteria solution using glycine buffer. The result showed us that extracted solution has strong ability to hydrolyze glycosyl. However, there’s no lactose in notoginseng solid medium. In order to reduce costs, another plasmid psb1C3 which contains T7 RNA Polymerase gene and was transformed into E.coli. Psb1C3 contains T7 RNA Polymerase gene and can be regulated by pBAD. This double-plasmid system is expected to be regulated by pPAD, and expresses a large number of T7RNA polymerase to inhibit the effect of LacI repression, switch on the expression ofβ-galactosidase. It’s been reported in bibliography that the cellwall of notoginseng contains a certain concentration of arabinose. Our ultimate goal is using notoginseng to provide nutrients for E.coli in a solid state fermentation jar, E.coli can deglycosylate saponin of notoginseng as well.

北京科技大学